GHRP-2 — Dosing & Research | Peptide Chats
Research information only. Not medical advice. 18+ only. Not FDA-approved for human therapeutic use.

GHRP-2

Also known as: Pralmorelin, Growth Hormone-Releasing Peptide-2, GPA 748, KP-102 D, KP-102 LN, KP-102D, KP-102LN, D-Ala-D-(β-naphthyl)-Ala-Ala-Trp-D-Phe-Lys-NH2

Growth Hormone Secretagogue (GHS) / Synthetic Growth Hormone-Releasing Peptide (GHRP); Ghrelin Receptor (GHS-R1a) Agonist

Research chemicalLast updated: October 31, 2026Based on 42 peer-reviewed studies

What it is

GHRP-2 is a peptide used to stimulate growth hormone release, both for diagnostic testing of GH deficiency and, off-label, for body composition and recovery. It works by activating the same receptor as ghrelin, the body's natural hunger and GH-signaling peptide. Not FDA-approved for therapeutic use; banned by WADA.

The scientific side

GHRP-2 is a synthetic hexapeptide (D-Ala-D-β-naphthyl-Ala-Ala-Trp-D-Phe-Lys-NH2) that acts as a potent agonist at the GHS-R1a (ghrelin) receptor, which is present at both the pituitary and hypothalamic levels (PMID 9465289, PMID 26551992). GHRP-2 stimulates GH secretion through a receptor and intracellular signaling pathway distinct from that of GHRH: in human acromegalic somatotrophs, GHRP-2 increases GH secretion mainly via the protein kinase C (PKC) pathway and does not act through the GHRH/GRF receptor (PMID 9688350, PMID 9798733). GHRP-2 also stimulates ACTH, cortisol, and prolactin secretion (PMID 9285939, PMID 10195374). Its GH-releasing activity is synergistic with GHRH (PMID 9465289, PMID 9186261). GHRP-2 binds to CD36, a scavenger receptor for oxidized LDL, and may suppress vascular oxidative stress independently of GH. It also attenuates PKC-mediated inflammatory signaling in granulosa cells via inhibition of p38, JNK, and NF-κB pathways. GH secretion induced by GHRP-2 is subject to negative feedback inhibition by somatostatin.

Class: Growth Hormone Secretagogue (GHS) / Synthetic Growth Hormone-Releasing Peptide (GHRP); Ghrelin Receptor (GHS-R1a) Agonist

Administration & storage

Administration
Intravenous bolus (PMID: 17609397PMID: 20662346PMID: 9543135PMID: 33197153PMID: 21249726PMID: 19907099)Intravenous continuous infusion (PMID: 10037246PMID: 12030918PMID: 10946861PMID: 15699539)Subcutaneous infusion (PMID: 15699539)Subcutaneous injection twice daily (PMID: 19819949 — animal study)Intranasal administration (PMID: 9390009PMID: 25869809)Oral administration (PMID: 21298258PMID: 12932743)
Storage
One abstract confirmed long-term stability of GHRP-2 in dried blood spot (DBS) samples for >2 years. No storage conditions for prepared solutions or lyophilized powder are described in the reviewed abstracts.
Cautions
GHRP-2 stimulates ACTH and cortisol secretion in addition to GH; this may confound interpretation of HPA-axis tests and represents an off-target endocrine effect (PMID: 9285939, PMID: 20431231).,GHRP-2 stimulates prolactin release; magnitude is lower than TRH but comparable across doses studied (PMID: 9285939, PMID: 10195374).,GHRP-2 can mask rhGH doping detection by increasing both recombinant and pituitary GH isoforms, altering the Rec/Pit ratio used in isoform immunoassay.,Black-market products labeled as GHRP-2 or related peptides may be mislabeled, adulterated, or contain novel analogues (e.g., Gly-GHRP-2) of unknown activity and safety (PMID: 29864719, PMID: 30051972).,No long-term human safety data are available from these abstracts; cancer incidence, mitogenic risk, and long-term metabolic consequences have not been established in rigorous controlled trials.,Sterile technique and appropriate clinical oversight are required for any injectable administration.

Legal & regulatory status

US FDA

Not stated in reviewed literature as currently FDA-approved. One abstract notes Wyeth (formerly American Home Products) discontinued US development for GH deficiency. WADA-prohibited for use in sport. Requires manual…

WADA

Listed on the WADA Prohibited List as a prohibited substance in sport (PMID: 20552695, PMID: 20431231, PMID: 25869809)

Health Canada

Not stated in reviewed literature — requires manual verification. Kaken sublicensed to Wyeth for US and Canada per PMID: 15230633; no approval stated.